These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34801358)

  • 1. Anastomotic leakage and chronic presacral sinus after transanal total mesorectal excision (taTME) for rectal cancer: A comparative study to laparoscopic TME.
    Jang HB; Kang SB; Lee H; Choi BJ; Lee SC
    Asian J Surg; 2022 Nov; 45(11):2197-2202. PubMed ID: 34801358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of open vs laparoscopic vs robotic vs transanal total mesorectal excision (TME) for rectal cancer: a network meta-analysis.
    Seow W; Dudi-Venkata NN; Bedrikovetski S; Kroon HM; Sammour T
    Tech Coloproctol; 2023 May; 27(5):345-360. PubMed ID: 36508067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of short-term clinical outcomes between transanal and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: A meta-analysis.
    Xu W; Xu Z; Cheng H; Ying J; Cheng F; Xu W; Cao J; Luo J
    Eur J Surg Oncol; 2016 Dec; 42(12):1841-1850. PubMed ID: 27697315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-Year Nationwide Experience with Transanal Total Mesorectal Excision for Rectal Cancer in the Netherlands: A Propensity Score-Matched Comparison with Conventional Laparoscopic Total Mesorectal Excision.
    Detering R; Roodbeen SX; van Oostendorp SE; Dekker JT; Sietses C; Bemelman WA; Tanis PJ; Hompes R; Tuynman JB;
    J Am Coll Surg; 2019 Mar; 228(3):235-244.e1. PubMed ID: 30639298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Risk Factors of Surgical Complications and Anastomotic Leakage After Transanal Total Mesorectal Excision for Middle and Low Rectal Cancer.
    Xu F; Li H; Guo C; Yang Z; Gao J; Zhang X; Wei Q; Meng C; Sun L; Wu G; Yao H; Zhang Z
    J Gastrointest Surg; 2023 Feb; 27(2):373-381. PubMed ID: 36538254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer.
    Veltcamp Helbach M; Koedam TWA; Knol JJ; Diederik A; Spaargaren GJ; Bonjer HJ; Tuynman JB; Sietses C
    Surg Endosc; 2019 Jan; 33(1):94-102. PubMed ID: 29967990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers.
    Zuhdy M; Elmore U; Shams N; Hegazy MAF; Roshdy S; Eldamshety O; Metwally IH; Rosati R
    J Laparoendosc Adv Surg Tech A; 2020 Jul; 30(7):769-776. PubMed ID: 32240035
    [No Abstract]   [Full Text] [Related]  

  • 10. Transanal versus laparoscopic total mesorectal excision: a comparative study of long-term oncological outcomes.
    Ourô S; Ferreira M; Roquete P; Maio R
    Tech Coloproctol; 2022 Apr; 26(4):279-290. PubMed ID: 35050434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer: A systematic review and meta-analysis.
    Yi Chi Z; Gang O; Xiao Li F; Ya L; Zhijun Z; Yong Gang D; Dan R; Xin L; Yang L; Peng Z; Yi L; Dong L; De Chun Z
    Medicine (Baltimore); 2024 Jan; 103(4):e36859. PubMed ID: 38277570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transanal (TaTME) vs. laparoscopic total mesorectal excision for mid and low rectal cancer: a propensity score-matched analysis of early and long-term outcomes.
    Munini M; Popeskou SG; Galetti K; Roesel R; Mongelli F; Christoforidis D
    Int J Colorectal Dis; 2021 Oct; 36(10):2271-2279. PubMed ID: 34467413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer.
    Rasulov AO; Mamedli ZZ; Gordeyev SS; Kozlov NA; Dzhumabaev HE
    Tech Coloproctol; 2016 Apr; 20(4):227-34. PubMed ID: 26794213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of transanal compared to laparoscopic total mesorectal excision (taTME vs. lapTME) for the treatment of mid-low rectal cancer in obese patients: outcomes of a multicenter propensity-matched analysis.
    Tejedor P; Arredondo J; Simó V; Zorrilla J; Baixauli J; Jiménez LM; Pastor C
    Updates Surg; 2023 Dec; 75(8):2191-2200. PubMed ID: 37903996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transanal total mesorectal excision-a critical appraisal].
    Holmer C; Benz S; Fichtner-Feigl S; Jehle EC; Kienle P; Post S; Schiedeck T; Weitz J; Kreis ME
    Chirurg; 2019 Jun; 90(6):478-486. PubMed ID: 30911795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta-analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision.
    Ma B; Gao P; Song Y; Zhang C; Zhang C; Wang L; Liu H; Wang Z
    BMC Cancer; 2016 Jul; 16():380. PubMed ID: 27377924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis.
    Aubert M; Mege D; Panis Y
    Surg Endosc; 2020 Sep; 34(9):3908-3919. PubMed ID: 31617090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of a Single Surgeon-Based Transanal-Total Mesorectal Excision (TATME) for Rectal Cancer.
    Caycedo-Marulanda A; Jiang HY; Kohtakangas EL
    J Gastrointest Cancer; 2018 Dec; 49(4):455-462. PubMed ID: 28702861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year outcome after transanal versus laparoscopic total mesorectal excision in locally advanced rectal cancer: a multicenter comparative analysis.
    de Lacy FB; Roodbeen SX; Ríos J; van Laarhoven J; Otero-Piñeiro A; Bravo R; Visser T; van Poppel R; Valverde S; Hompes R; Sietses C; Castells A; Bemelman WA; Tanis PJ; Lacy AM
    BMC Cancer; 2020 Jul; 20(1):677. PubMed ID: 32689968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.